CLINT MALCOM: Open Payments
NPI 1689620650 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$186 in 8 payments from 6 companies in 2025. Trend: 2023 $1,343 · 2024 $1,116 · 2025 $186
Food & beverage: $186
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Supernus Pharmaceuticals, Inc. | 1 | $36 |
| Lundbeck LLC | 1 | $23 |
| ABBVIE INC. | 1 | $22 |
| Alkermes, Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: REXULTI, ABILIFY MAINTENA, Qelbree, VRAYLAR, ARISTADA, Auvelity.
Industry payments across NE — which companies pay providers there.
